Establishing Impurity Specifications for Antibiotics
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 20, 2026
April 17, 2026
5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84
Related Documents
Data Integrity for In Vivo Bioavailability and Bioequivalence Studies
Guidance DocumentApril 3, 2024Center for Drug Evaluation and Research
Quality Considerations for Topical Ophthalmic Drug Products
Guidance DocumentDecember 27, 2023Center for Drug Evaluation and Research
Benefit-Risk Considerations for Product Quality Assessments
Guidance DocumentMay 9, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox